Cite
HARVARD Citation
Hisamatsu, T. et al. (n.d.). DOP32 Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2). Journal of Crohn's and colitis. pp. S043-S044. [Online].